Sphygmomanometers (aneroid sphygmomanometers, mercury sphygmomanometers, and digital sphygmomanometers), automated blood pressure monitors, ambulatory blood pressure monitors, blood pressure transducers, and blood pressure instrument accessories are all used in blood pressure monitoring and testing.
Recent Happenings:
Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, today announced the launch of its new wearable and continuous ambulatory blood pressure monitoring (ABPM) chest-monitoring device, which will be available on May 26, 2021.
To minimize cross-contamination and reduce the spread of COVID-19, Vancouver Coastal Health, a regional health authority, replaced its reusable blood pressure cuffs with disposable ones in July 2020, resulting in an increase in demand for disposable Blood Pressure Monitoring Testing Market cuffs among its affiliated members.
Omron Healthcare Inc. and Mount Sinai Health Institution (New York City's largest academic medical system) collaborated in July 2020 to bring the new VitalSight home blood pressure monitoring solution to patients.
In terms of volume, North America dominated the worldwide blood pressure monitoring testing market in 2020, accounting for 44.9 percent of the market, followed by Europe and the Asia Pacific. The rising frequency of heart disorders, more product introductions in recent years, and expanding acceptance of home blood pressure monitors in the region would all contribute to the market's growth in the forecast period. According to the Centers for Disease Control and Prevention (CDC), hypertension was a primary or contributing cause of roughly half a million fatalities in the United States in 2018, and nearly half of individuals (45 percent) with uncontrolled hypertension have a blood pressure of 140/90 mm Hg or above. This comprises 37 million adults in the United States.
Opportunities in the Global Blood Pressure Monitoring Testing Market
The rising frequency of cardiovascular disorders in emerging economies is likely to provide lucrative growth prospects for worldwide blood pressure monitoring testing market participants. According to a study published in July 2018 in the Journal of the American College of Cardiology titled "Cardiovascular Diseases in India Compared With the United States," the estimated age-standardized prevalence of CVD in India in 2016 was 5,681 per 100,000.
0 Comments